[PDF][PDF] An empirical study of employment and disability over three years among survivors of major disasters

SS Rasco, CS North - Journal of the American Academy of …, 2010 - scholar.archive.org
This study was designed to clarify the relationship between exposure to disaster and future
employment. Survivors of seven disasters and their employment histories were prospectively …

[PDF][PDF] Flexibly Planar and Flexibly Flat Graphs

P Bonventre, L Garcıa, A Murray, S Rasco, J Foisy - 2012 - Citeseer
We say a graph G is flexibly planar if and only if for every cycle in G, there exists a planar
embedding of G such that the cycle bounds a disk whose interior is disjoint from G. We show …

A first-in-human study of novel cereblon modulator avadomide (CC-122) in advanced malignancies

DW Rasco, KP Papadopoulos, M Pourdehnad… - Clinical Cancer …, 2019 - AACR
Purpose: Avadomide is a novel, small-molecule therapeutic agent that modulates cereblon
E3 ligase activity and exhibits potent antitumor and immunomodulatory activities. This first-in-…

[HTML][HTML] 659 COM701 plus nivolumab demonstrates preliminary antitumor activity and immune modulation of tumor microenvironment in patients with metastatic MSS …

D Rasco, E Dumbrava, M Sharma, D Shepard… - 2022 - jitc.bmj.com
Background COM701 a novel, 1st in-class, humanized IgG4 monoclonal antibody binds with
high affinity to PVRIG, blocking its interaction with its natural ligand PVRL2 expressed in …

Phase I study of CC-486 alone and in combination with carboplatin or nab-paclitaxel in patients with relapsed or refractory solid tumors

DD Von Hoff, DW Rasco, EI Heath, PN Munster… - Clinical Cancer …, 2018 - AACR
Purpose: This large two-part, three-arm phase I study examined the safety and tolerability of
CC-486 (an oral formulation of azacitidine, a hypomethylating agent) alone or in …

A phase I study evaluating COM701 in patients with advanced solid tumors.

DW Rasco, DA Vaena, RJ Sullivan, JJ Luke… - 2019 - ascopubs.org
TPS2657 Background: There is a high unmet medical need for the treatment (tx) of patients (pt)
who are refractory to or relapse following tx with checkpoint inhibitors. Newer checkpoint …

COM701 with or without nivolumab: Results of an ongoing phase 1 study of safety, tolerability and preliminary antitumor activity in patients with advanced solid …

…, R Smith, EA Lim, EE Dumbrava, DW Rasco - 2021 - ascopubs.org
2504 Background: COM701 is a novel first in class humanized IgG4 monoclonal antibody
that binds with high affinity to poliovirus receptor related immunoglobulin domain containing (…

Pharmacokinetic/biomarker (PK/BMx) analysis of the toll-like receptor 7 and 8 (TLR7/8) agonist EIK1001 in phase 1 studies in participants (Pts) with solid tumors

D Rasco, M Patel, M Johnson, A Tolcher… - Cancer Research, 2024 - AACR
Introduction: Immune checkpoint inhibitors (ICIs) relieve immunosuppression of tumor-reactive
T cells and enhance antitumor immune response; however, not all patients benefit and …

[BOOK][B] Detecting gauge structure beyond the standard model

BC Rasco - 1996 - search.proquest.com
Extentions of the standard model abound and it is important to be able to distinguish signals
of new physics. This dissertation focuses on one extention of the standard model, the $ SU (…

[PDF][PDF] Using afterschool and summer learning to improve literacy skills

CH Rasco, JB Cheatham… - Expanding and …, 2013 - expandinglearning.org
In addition, many low-income students miss too much instructional time as a result of chronic
absenteeism in the early grades. As many as 25% of low-income students in urban school …